MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MEIP MEI Pharma

盘后交易 12-24 14:04:33 EST

2.36

+0.00

0.00%

盘后2.34

-0.02-0.85%

13:00 EST

最高2.50	最低2.36	成交量8,614
今开2.39	昨收2.36	日振幅6.08%
总市值1,572万	流通市值1,163万	总股本666.29万
成交额2.09万	换手率0.17%	流通股本492.73万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MEIP","market":"US","secType":"STK","nameCN":"MEI Pharma","latestPrice":2.36,"timestamp":1735063080011,"preClose":2.36,"halted":0,"volume":8614,"hourTrading":{"tag":"盘后","latestPrice":2.34,"preClose":2.36,"latestTime":"13:00 EST","volume":49,"amount":114.66,"timestamp":1735063201192},"delay":0,"floatShares":4927260,"shares":6662857,"eps":-6.994296,"marketStatus":"盘后交易","marketStatusCode":4,"change":0,"latestTime":"12-24 14:04:33 EST","open":2.39,"high":2.5035,"low":2.36,"amount":20925.5388264,"amplitude":0.060805,"askPrice":2.59,"askSize":17,"bidPrice":2.31,"bidSize":19,"shortable":3,"etf":0,"ttmEps":-6.994296,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735077600000},"adr":0,"listingDate":1071723600000,"adjPreClose":2.36,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.34,"preClose":2.36,"latestTime":"13:00 EST","volume":49,"amount":114.66,"timestamp":1735063201192},"volumeRatio":0.168442,"impliedVol":0.0287,"impliedVolPercentile":0.0238},"requestUrl":"/m/hq/s/MEIP","defaultTab":"news","newsList":[{"id":"2493872920","title":"Mei Pharma, Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493872920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493872920?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:42","pubTimestamp":1735051357,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时42分，Mei Pharma, Inc.股票出现波动，股价快速上涨5.24%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224237984d85da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224237984d85da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2493962437","title":"Mei Pharma, Inc.盘中异动 大幅下跌7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493962437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493962437?lang=zh_cn&edition=full","pubTime":"2024-12-24 01:55","pubTimestamp":1734976536,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时55分，Mei Pharma, Inc.股票出现波动，股价快速下跌7.20%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为916.75%、874.67%、849.36%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.，振幅分别为157.37%、104.19%、96.28%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224015536984d3e22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224015536984d3e22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2492061149","title":"Mei Pharma, Inc.盘中异动 临近午盘大幅下挫5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492061149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492061149?lang=zh_cn&edition=full","pubTime":"2024-12-17 00:50","pubTimestamp":1734367807,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日00时50分，Mei Pharma, Inc.股票出现异动，股价快速跳水5.93%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217005008984c739b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217005008984c739b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2490686721","title":"Mei Pharma, Inc.盘中异动 大幅跳水5.31%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490686721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490686721?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:43","pubTimestamp":1733935400,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日00时43分，Mei Pharma, Inc.股票出现异动，股价急速下挫5.31%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Candel Therapeutics, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为443.35%、188.16%、103.39%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Candel Therapeutics, Inc.、Biora Therapeutics, Inc.，振幅分别为127.38%、104.12%、69.68%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212004321ab70099c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212004321ab70099c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MEIP","BK4139","CADL"],"gpt_icon":0},{"id":"2483306766","title":"Mei Pharma, Inc.2024财年第三财季实现净利润-8.01百万美元，同比减少114.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306766?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686436,"startTime":"0","endTime":"0","summary":"11月16日，Mei Pharma, Inc.公布财报，公告显示公司2024财年第三财季净利润为-8.01百万美元，同比减少114.21%；其中营业收入为0.00美元，每股基本收益为-1.20美元。从资产负债表来看，Mei Pharma, Inc.总负债2.87百万美元，其中短期债务0.00美元，资产负债比为9.67，流动比率为9.67。机构评级：截至2024年11月16日，当前有3家机构对Mei Pharma, Inc.目标价做出预测，其中目标均价为22.67美元，其中最低目标价为6.00美元，最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000323abc51610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000323abc51610&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP"],"gpt_icon":0},{"id":"2483930594","title":"Mei Pharma, Inc.盘中异动 早盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483930594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483930594?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:38","pubTimestamp":1731685104,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时38分，Mei Pharma, Inc.股票出现异动，股价急速下挫5.18%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为3.26%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115233824971a6e5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115233824971a6e5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2478486705","title":"Mei Pharma, Inc.盘中异动 早盘股价大涨8.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486705?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:30","pubTimestamp":1730122243,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时30分，Mei Pharma, Inc.股票出现波动，股价大幅拉升8.06%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213044971a2a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213044971a2a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2468507320","title":"Mei Pharma, Inc.盘中异动 大幅上涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468507320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468507320?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:22","pubTimestamp":1726762967,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日00时22分，Mei Pharma, Inc.股票出现异动，股价急速上涨5.55%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。其相关个股中，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4577.95%、875.83%、201.75%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为101.31%、78.69%、52.97%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092000224798e38240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092000224798e38240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2459094304","title":"Mei Pharma, Inc.盘中异动 股价大跌5.01%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459094304","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459094304?lang=zh_cn&edition=full","pubTime":"2024-08-16 02:32","pubTimestamp":1723746739,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日02时32分，Mei Pharma, Inc.股票出现波动，股价快速下跌5.01%。截至发稿，该股报3.22美元/股，成交量1.4565万股，换手率0.22%，振幅6.78%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816023220a1d476d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816023220a1d476d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2457282646","title":"Mei Pharma, Inc.盘中异动 临近午盘大幅拉升5.54%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457282646","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457282646?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:46","pubTimestamp":1723045601,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日23时46分，Mei Pharma, Inc.股票出现波动，股价快速拉升5.54%。截至发稿，该股报3.56美元/股，成交量6832股，换手率0.10%，振幅3.26%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为2.09%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080723464196824d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080723464196824d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2457070078","title":"Mei Pharma, Inc.盘中异动 临近午盘大幅跳水5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457070078","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457070078?lang=zh_cn&edition=full","pubTime":"2024-08-06 23:55","pubTimestamp":1722959711,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日23时55分，Mei Pharma, Inc.股票出现异动，股价大幅跳水5.49%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为2.37%。其相关个股中，Vbi Vaccines, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Alpha Tau Medical Ltd C/Wts 涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1276.00%、1273.34%、387.30%，振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为168.52%、81.76%、78.49%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806235512af963692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806235512af963692&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2456322614","title":"Mei Pharma, Inc.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456322614","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456322614?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:08","pubTimestamp":1722524932,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时08分，Mei Pharma, Inc.股票出现异动，股价急速下跌5.12%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Dermata Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为285.89%、198.20%、106.39%，振幅较大的相关个股有Immuneering Corporation、Windtree Therapeutics, Inc.、Dermata Therapeutics, Inc.，振幅分别为40.71%、40.35%、39.53%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080123085396822bad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080123085396822bad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4539","MEIP","IMRX"],"gpt_icon":0},{"id":"2456162631","title":"Mei Pharma, Inc.盘中异动 急速拉升6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456162631","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456162631?lang=zh_cn&edition=full","pubTime":"2024-08-01 03:55","pubTimestamp":1722455714,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日03时55分，Mei Pharma, Inc.股票出现波动，股价快速拉升6.14%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Windtree Therapeutics, Inc.、Molecular Partners Ag、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为817.27%、179.81%、167.21%，振幅较大的相关个股有Molecular Partners Ag、Renovaro Inc.、Windtree Therapeutics, Inc.，振幅分别为89.73%、79.10%、63.20%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801035515968225e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801035515968225e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2454830804","title":"Mei Pharma, Inc.盘中异动 股价大涨5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454830804","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454830804?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:40","pubTimestamp":1721925605,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时40分，Mei Pharma, Inc.股票出现异动，股价大幅上涨5.74%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃，换手率分别为4362.71%、552.79%、278.66%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为152.48%、132.26%、98.60%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726004005af9422f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726004005af9422f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2453600010","title":"Mei Pharma, Inc.盘中异动 早盘股价大跌5.45%报3.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453600010","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453600010?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:38","pubTimestamp":1721828290,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日21时38分，Mei Pharma, Inc.股票出现异动，股价急速跳水5.45%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Pieris Pharmaceuticals, Inc.、Dermata Therapeutics Inc C/Wts 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Azitra Inc、Hoth Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为916.72%、485.01%、448.57%，振幅较大的相关个股有Dermata Therapeutics Inc C/Wts 、Pieris Pharmaceuticals, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为47.62%、28.82%、28.27%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724213810941fa27c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724213810941fa27c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2453543140","title":"Mei Pharma, Inc.盘中异动 临近午盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453543140","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453543140?lang=zh_cn&edition=full","pubTime":"2024-07-23 23:40","pubTimestamp":1721749231,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日23时40分，Mei Pharma, Inc.股票出现异动，股价急速拉升5.19%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为6722.21%、5276.58%、3373.52%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc，振幅分别为366.13%、365.43%、137.74%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723234031941f9ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723234031941f9ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2453797395","title":"BUZZ--美国股票走势-威瑞森通信、Reddit、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2453797395","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453797395?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:54","pubTimestamp":1721663649,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      7月22日 - 在拜登总统退出竞选后，投资者对共和党提名人特朗普在 11 月大选中连任的可能性进行了评估。美东时间11:37，道琼斯工业平均指数  持平于40,289.04点。标普500指数  上涨0.52%，报5533.54点；纳斯达克综合指数  上涨0.73%，报17856.568点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID",".SPX","DDM","IQV","VSTO","NQmain","CHRW","DXD","NEM","LU1718418525.SGD","TXG","GT","LU1303367103.USD",".DJI","MNQmain","SNDR","SBUX","SDOW","SQQQ","DJX","QLD","IPG","TQQQ","CLW","BUZZ","LU1974910355.USD","PSQ","UDOW","BKNG","VZ","LU2133065610.SGD","DOG","MEIP",".IXIC","S","RDDT","ZS","GL","SAVA"],"gpt_icon":1},{"id":"2453799961","title":"BUZZ-MEI Pharma 因裁员计划而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2453799961","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453799961?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:42","pubTimestamp":1721659333,"startTime":"0","endTime":"0","summary":"    7月22日 - ** MEI Pharma   股价上涨33.2%，达到3.81美元的三个多月高点** 如果涨势保持，股价将创10个月来最佳表现** 公司称 \"将在可行的情况下尽快开始裁员\"，以保留现有现金** MEIP 首席执行官 David M. Urso 和首席医疗官 Richard Ghalie 也将于 8 月 1 日离职，以保留现金** 公司现任首席财务官 Justin File 将担任代理首席执行官，领导公司度过过渡期** MEIP打算停止药物voruciclib的临床开发** 如果找不到有利的战略替代方案，公司将考虑有序关闭业务\"- Justin File ** 年初至今，股价下跌了 35.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","BK4145","MEIP","MEI"],"gpt_icon":0},{"id":"2453798413","title":"Mei Pharma, Inc.盘中异动 早盘股价大涨12.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453798413","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453798413?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:31","pubTimestamp":1721655082,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时31分，Mei Pharma, Inc.股票出现波动，股价快速拉升12.38%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Enveric Biosciences, Inc.、Mei Pharma, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为92.67%、77.48%、15.70%，振幅较大的相关个股有Exicure, Inc.、Dbv Technologies、Inmune Bio Inc.，振幅分别为13.38%、8.21%、7.80%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222131229edf3359&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222131229edf3359&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2453764257","title":"MEI Pharma公司 - 主席Charles Baltic III将辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2453764257","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453764257?lang=zh_cn&edition=full","pubTime":"2024-07-22 20:30","pubTimestamp":1721651434,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4145","MEI","BK4139","MEIP","BK4134","III"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.meipharma.com","stockEarnings":[{"period":"1week","weight":-0.0853},{"period":"1month","weight":-0.1511},{"period":"3month","weight":-0.2},{"period":"6month","weight":-0.1748},{"period":"1year","weight":-0.6218},{"period":"ytd","weight":-0.5931}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MEI Pharma, Inc.是一家临床阶段的制药公司，致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道，并通过临床开发、战略合作伙伴关系以及外包许可或商业化（视情况而定）在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.057007},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.001286},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.071045},{"month":4,"riseRate":0.571429,"avgChangeRate":0.02424},{"month":5,"riseRate":0.428571,"avgChangeRate":0.036458},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.091782},{"month":7,"riseRate":0.333333,"avgChangeRate":0.028904},{"month":8,"riseRate":0.4,"avgChangeRate":-0.008632},{"month":9,"riseRate":0.55,"avgChangeRate":0.077177},{"month":10,"riseRate":0.4,"avgChangeRate":-0.06033},{"month":11,"riseRate":0.45,"avgChangeRate":-0.037118},{"month":12,"riseRate":0.238095,"avgChangeRate":0.015969}],"exchange":"NASDAQ","name":"MEI Pharma","nameEN":"MEI Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MEI Pharma,MEIP,MEI Pharma股票,MEI Pharma股票老虎,MEI Pharma股票老虎国际,MEI Pharma行情,MEI Pharma股票行情,MEI Pharma股价,MEI Pharma股市,MEI Pharma股票价格,MEI Pharma股票交易,MEI Pharma股票购买,MEI Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}